Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs WeightCare

Alan Meds
Graded #98

Higher grade

vs+12.499999999999993
WeightCare
Graded #368

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 58.6/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +37
72
35
Dose & formulationAlan Meds +13
75
62
Clinical oversightWeightCare +5
82
87
Labs & monitoringWeightCare +1
53
54
FulfillmentAlan Meds +6
78
72
Contract termsAlan Meds +14
55
41
Alan Meds · left barWeightCare · right bar

The numbers

MetricAlan MedsWeightCare
WeighScore71.1/10058.6/100
GradeCC
Scorecard rank#98#368
Semaglutide$158/mo (compounded)$399/mo
Tirzepatide$295/mo (compounded)$499/mo (15 mg dose, compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
WeightCare

Graded #368 · C

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard